Arc 7A Cure Within Reach
Wei Kang transformed Sanqing into a research powerhouse, launching the Wei Science Award and an AI Pharmaceutical System while expanding into gene therapy. Sanqing’s SMA treatment restored children’s health and forced drugmakers to cut prices, and Wei Kang then pledged to help Cao Yang develop a gene therapy for Menkes disease.
- Mabus praised Wei Kang in a widely watched interview, boosting Three Purities’ overseas beauty sales as Sanqing’s products expanded into new markets.
- Wei Kang rewarded Wenren Long, Xiang Gaofei, and Li Zhong for their research, while Sanqing expanded its laboratories and recruited researchers.
- Wei Kang founded the Wei Science Award with support from academicians and upgraded the Intelligent Laboratory System into an AI Pharmaceutical System.
- Wei Kang named Number One Anmei and ordered her to monitor Williams, the researcher who had installed a backdoor for an Eagle Country agency.
- Tang Que launched Sanqing’s SMA gene-therapy program, and the laboratory used AICell to reproduce existing treatments and develop its own therapy.
- Chen Jianfeng enrolled both Nini and Xiao Jian in Sanqing’s clinical trial, where the children and other SMA patients rapidly regained strength and were discharged.
- Wei Kang announced the successful trial results, set the domestic drug price at 300,000 yuan per injection, and offered donated treatment to extremely impoverished patients.
- Wei Kang agreed to develop a Menkes disease gene therapy after Cao Yang described his research and his efforts to help his son Xiao Wei and other families.